Chesson Labs | Products

Chesson Labs’ products are based on innovative patented and patent-pending polymer chemistry. Our products cleared for market and in development include treatments for use by consumers and medical professionals.

Liquid Bandage Product

Chesson Labs Liquid Bandage is an innovative new health care product. The product’s FDA 510(k) clearance allows the Company to market and sell the product for use by healthcare professionals and directly to consumers. The product’s FDA cleared claims are to cover intact skin or minor cuts, scrapes, burns and minor irritations of the skin, to help keep them clean and dry and help protect them from infection. Chesson Labs Liquid Bandage will initially be marketed to the United States Military and medical professionals.

NUVADERM First Aid is a liquid bandage product for use by medics and personnel in the United States Armed Forces.

NSN# 6510015866314

For more information please visit http://www.NUVADERM.com

NUVADERM is a liquid bandage product for use by medical professionals and consumers.

Consumers in NC, SC, and VA can purchase the product at their nearest Mutual Drug. To find the nearest outlet to you please visit http://www.mutualdrugcompany.com.

For more information, and for all other customers, please visit http://www.NUVADERM.com.

NUVAVET is an Animal Healthcare Bandage.

For more information, please visit www.NUVAVET.com

Nail Fungus treatmenT

LIQUICURE® is intended to be a biocompatible topical onychomycosis treatment. Onychomycosis, commonly referred to as toenail fungus, is a disease which currently affectsestimated 35-40 million Americans, and more than 8% of the world’s population. It is estimated that 50% or more of the cases currently go untreated. The product is a polymer which is applied in liquid form with a foam applicator directly to the nail. Chesson Labs is currently sponsoring a clinical trial to evaluate the safety and effectivness of LIQUICURE®.(The claims and uses for this product have not been cleared by the FDA)

Research and Development

Through relationships with East Carolina University and leading U.S. based service providers, Chesson Labs has access to world class resources that are fueling the growth and the future of Chesson Labs. The Company sees additional uses for its current and future technology though internal funding, partnerships with other organizations, and grants. The Company will continue to develop new and novel products that will not only add value to the Company, but that will also continue to help people.


	Products About Us \| Management \| Products \| Partnerships \| News \| Investors Home \| Contact \| Legal
	Chesson Labs’ products are based on innovative patented and patent-pending polymer chemistry. Our products cleared for market and in development include treatments for use by consumers and medical professionals. Liquid Bandage Product Chesson Labs Liquid Bandage is an innovative new health care product. The product’s FDA 510(k) clearance allows the Company to market and sell the product for use by healthcare professionals and directly to consumers. The product’s FDA cleared claims are to cover intact skin or minor cuts, scrapes, burns and minor irritations of the skin, to help keep them clean and dry and help protect them from infection. Chesson Labs Liquid Bandage will initially be marketed to the United States Military and medical professionals. NUVADERM First Aid is a liquid bandage product for use by medics and personnel in the United States Armed Forces. NSN# 6510015866314 For more information please visit http://www.NUVADERM.com NUVADERM is a liquid bandage product for use by medical professionals and consumers. Consumers in NC, SC, and VA can purchase the product at their nearest Mutual Drug. To find the nearest outlet to you please visit http://www.mutualdrugcompany.com. For more information, and for all other customers, please visit http://www.NUVADERM.com. NUVAVET is an Animal Healthcare Bandage. For more information, please visit www.NUVAVET.com Nail Fungus treatmenT LIQUICURE® is intended to be a biocompatible topical onychomycosis treatment. Onychomycosis, commonly referred to as toenail fungus, is a disease which currently affectsestimated 35-40 million Americans, and more than 8% of the world’s population. It is estimated that 50% or more of the cases currently go untreated. The product is a polymer which is applied in liquid form with a foam applicator directly to the nail. Chesson Labs is currently sponsoring a clinical trial to evaluate the safety and effectivness of LIQUICURE®.(The claims and uses for this product have not been cleared by the FDA) Research and Development Through relationships with East Carolina University and leading U.S. based service providers, Chesson Labs has access to world class resources that are fueling the growth and the future of Chesson Labs. The Company sees additional uses for its current and future technology though internal funding, partnerships with other organizations, and grants. The Company will continue to develop new and novel products that will not only add value to the Company, but that will also continue to help people.